Tetanus
What's New
Last Posted: Mar 07, 2023
- Tetanus-diphtheria vaccination in adults: the long-term persistence of antibodies is not dependent on polyclonal B-cell activation and the defective response to diphtheria toxoid re-vaccination is associated to HLADRB1?01.
Ferlito Claudia, et al. Vaccine 2018 0 (45) 6718-6725 - Comparative Analysis of T-Cell Responses to Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein in Inflammatory Demyelinating Central Nervous System Diseases.
Hofer Livia Sophie, et al. Frontiers in immunology 2020 0 1188 - Genetic predisposition to adverse events in Chinese children aged 3-24 months after diphtheria, tetanus, acellular pertussis and haemophilus influenzae type b combined vaccination.
Ma Yujia, et al. Expert review of vaccines 2022 0 (12) 1923-1928 - HLA-DR3 restricted environmental epitopes from the bacterium Clostridium tetani have T cell cross-reactivity to the SLE-related autoantigen SmD.
Zhao Zhenhuan, et al. Frontiers in immunology 2022 0 928374 - The impact of women's political representation on child health outcomes during 1990-2020: Evidence from a global dataset.
Rustagi Niharika, et al. Social science & medicine (1982) 2022 0 115366 - Antibodies to several citrullinated antigens are enriched in the joints of rheumatoid arthritis patients.
Snir Omri, et al. Arthritis and rheumatism 2009 0 (1) 44-52 - [Artificial intelligence-based literature data warehouse for vaccine safety].
Yang Y et al. Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi 2022 43(3) 431-435 - Common Genetic Variations Associated with the Persistence of Immunity following Childhood Immunization.
O'Connor Daniel, et al. Cell reports 2019 6 (11) 3241-3253.e4 - 2019 Digital Toolkit: NATIONAL BIRTH DEFECTS PREVENTION MONTH
- Vaccines: Life savers against infectious diseases
Wellcome Trust Sanger Blog, August 2, 2019
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 19, 2024
- Content source: